Annovis Bio Inc (ANVS)

Currency in USD
2.66
+0.09(+3.50%)
Closed·
After Hours
2.64-0.02(-0.77%)
·
ANVS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ANVS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.532.70
52 wk Range
1.1111.29
Key Statistics
Prev. Close
2.57
Open
2.56
Day's Range
2.53-2.7
52 wk Range
1.11-11.29
Volume
367K
Average Volume (3m)
449.38K
1-Year Change
-75.02%
Book Value / Share
1.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANVS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.25
Upside
+435.71%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Annovis Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Annovis Bio Inc Company Profile

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer’s disease, as well as in phase 3 to treat parkinson’s disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer’s disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Compare ANVS to Peers and Sector

Metrics to compare
ANVS
Peers
Sector
Relationship
P/E Ratio
−1.8x−2.0x−0.5x
PEG Ratio
−0.03−0.080.00
Price/Book
2.2x0.8x2.6x
Price / LTM Sales
-90.8x3.2x
Upside (Analyst Target)
-197.2%41.9%
Fair Value Upside
Unlock18.6%4.3%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 14.25
(+435.71% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.32 / -0.38
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ANVS Income Statement

People Also Watch

47.850
SMR
+7.67%
29.42
CNC
+5.49%
5.050
LVWR
+26.88%
126.05
CRWV
-2.87%
30.80
YOU
+3.18%

FAQ

What Stock Exchange Does Annovis Bio Trade On?

Annovis Bio is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Annovis Bio?

The stock symbol for Annovis Bio is "ANVS."

What Is the Annovis Bio Market Cap?

As of today, Annovis Bio market cap is 51.83M.

What Is Annovis Bio's Earnings Per Share (TTM)?

The Annovis Bio EPS (TTM) is -2.09.

When Is the Next Annovis Bio Earnings Date?

Annovis Bio will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is ANVS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Annovis Bio Stock Split?

Annovis Bio has split 0 times.

How Many Employees Does Annovis Bio Have?

Annovis Bio has 12 employees.

What is the current trading status of Annovis Bio (ANVS)?

As of 24 Jul 2025, Annovis Bio (ANVS) is trading at a price of 2.66, with a previous close of 2.57. The stock has fluctuated within a day range of 2.53 to 2.70, while its 52-week range spans from 1.11 to 11.29.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.